Dr. Andre R. Paixao, MD

Dr. Paixao practices at Arkansas Heart Hospital in Little Rock, Arkansas, part of Arkansas Heart Hospital.

Dr. Paixao's NPI, 1801051909, was assigned on July 28, 2008. Dr. Paixao holds Arkansas license E-9207.

Dr. Paixao's primary practice is Arkansas Heart Hospital, at 1701 S Shackleford Road, Little Rock, AR 72211 in Pulaski County. The practice phone is (501) 219-7000.

Dr. Paixao's primary practice is Arkansas Heart Hospital in Little Rock, Arkansas, part of Arkansas Heart Hospital. Dr. Paixao is also affiliated with CHRISTUS St. Michael Hospital. The medical group on file is Arkansas Heart Hospital Clinic (Little Rock Clinic). Dmand AI also links Dr. Paixao to 3 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Paixao practices, 7 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Paixao's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Paixao is licensed in Arkansas.

CMS data shows 9,582 Medicare services from Dr. Paixao across 50 procedure codes in 2024, for 2,877 Medicare patients. Medicare paid $632,337 for them.

CMS counts 2,877 Medicare patients who saw Dr. Paixao in 2024. The largest group is 65 to 74, with 1,230 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.25, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Paixao's median patient age at 74, with 49% women.

In 2024, Dr. Paixao wrote 13,679 Medicare Part D claims for 1,791 patients. 83% of them were for generic drugs. CMS names the drug for 13,461 of them, across 66 drugs with 11 or more claims each, at $2,510,640 in total drug cost. In 2023, CMS named 12,453 claims across 67 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Paixao for performance year 2024, reported as part of a group. Dr. Paixao accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 95 procedures of coronary angioplasty and stenting by Dr. Paixao, more than 96% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 20 papers to Dr. Paixao, published from 2013 to 2022. 2014 was the busiest year, with 3. The most frequent topics are Predictive Value of Tests, Coronary Angiography and Coronary Artery Disease. Dr. Paixao has published most often in Cardiovasc Revasc Med. Dr. Paixao's most frequent co-authors are James Andrew De Lemos, MD, Jarett D. Berry, MD and Amit Khera, MD, MS.

Dmand AI links Dr. Paixao to 4 clinical trials. Conditions studied include Coronary Stenosis, Heart Failure and Hemorrhagic Stroke. Abbott Medical Devices sponsors the most, 2.

CMS Open Payments shows 628 general payments to Dr. Paixao from 34 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 77% of the total. Janssen Pharmaceuticals, Inc paid the most, $101,536.